BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.verified

BML.WA

Price:

$5.8

Market Cap:

$267.52M

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A., a biotechnology company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland. The company's prescription drugs include Distreptaza, a medication used in gynecology for treating chronic inflammatory disease of the uterine appendages and hemorrhoids; Onko BCG 50, a product used in treating superficial (non-muscle invasive) bladder tumour; GAMMA anty HBs 200 medications for passive immunization against hepatitis B; GAMMA anty-D 50 and GAMMA anty-D 150, which are Anti D (Rho) immunoglobulin products used in prevention of hemolytic disease of the foetus and newborn; BioTrombina 400, a medication for topi...[Read more]

Industry

Biotechnology

IPO Date

2011-07-29

Stock Exchange

WSE

Ticker

BML.WA

The ROE as of December 2025 (TTM) for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) is 6.31%

According to BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.’s latest financial reports and current stock price. The company's current ROE is 6.31%. This represents a change of 310.09% compared to the average of 1.54% of the last 4 quarters.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Historical ROE (quarterly & annually)

How has BML.WA ROE performed in the past?

The mean historical ROE of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. over the last ten years is -233.35%. The current 6.31% ROE has changed -102.70% with respect to the historical average. Over the past ten years (40 quarters), BML.WA's ROE was at its highest in in the December 2017 quarter at 21.22%. The ROE was at its lowest in in the December 2016 quarter at -934.07%.

Quarterly (TTM)
Annual

Average

-233.35%

Median

4.96%

Minimum

-2083.05%

Maximum

11.90%

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) ROE by Quarter and Year

Discovering the peaks and valleys of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.02%

Maximum Annual ROE = 11.90%

Minimum Annual Increase = -65399.59%

Minimum Annual ROE = -2083.05%

Quarterly (TTM)
Annual
YearROEChange
20246.22%47.14%
20234.22%-26.67%
20225.76%1.08%
20215.70%-52.10%
202011.90%57.50%
20197.55%-107.09%
2018-106.62%-10581.97%
20171.02%-100.05%
2016-2083.05%1.02%
2015-186.17%-65399.59%

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Average ROE

How has BML.WA ROE performed in the past?

The current ROE of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

5.40%

5-year avg

6.76%

10-year avg

-233.35%

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) ROE vs. Peers

How is BML.WA’s ROE compared to its peers?

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.’s ROE is less than KGHM Polska Miedz S.A. (8.10%), less than Allegro.eu S.A. (10.97%), less than Polski Koncern Naftowy ORLEN Spólka Akcyjna (7.23%), less than Powszechny Zaklad Ubezpieczen S.A. (19.08%), less than CD Projekt S.A. (16.33%),

Build a custom stock screener for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.'s ROE?

How is the ROE calculated for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA)?

What is the highest ROE for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA)?

What is the 3-year average ROE for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA)?

What is the 5-year average ROE for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA)?

How does the current ROE for BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) compare to its historical average?